Charoen Pokphand Indonesia Tbk vs Merck Tbk. — how do they compare? Charoen Pokphand Indonesia Tbk trades at Rp3,070 (market cap 50.34T), while Merck Tbk. trades at Rp3,800 (market cap 1.7T). The key difference: Charoen Pokphand Indonesia Tbk is far larger — about 29.6× Merck Tbk.'s market cap. Which is the better fit depends on your goals.
| CPIN | MERK | |
|---|---|---|
Market Cap | 50.34T | 1.7T |
Trailing returns across standard periods
Latest headlines on both assets
PT Charoen Pokphand Indonesia Tbk (the Company) was established in Indonesia within the framework of Foreign Investment Law No. 1 year 1967 based on Notarial Deed No. 6 dated January 7, 1972 of Drs. Gde ngurah Rai, S.H. PT Charoen Pokphand Indonesia (CPI) established by CP Overseas Investment Co. Ltd., Hongkong. CPI is one of Indonesia leading agribusiness companies, with a clear focus on the formulation and production of poultry feed and the breeding of top quality poultry stock for Indonesian market. CPI is supported by expertise and experience of the established Charoen Pokphand Group of Thailand. The company has a fabrication plant, research and development facilities and breeding centers.
Read more on CPIN →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →